中性粒与淋巴细胞比在糖尿病视网膜病变中的应用价值
Application Value of Neutrophil to Lymphocyte Ratio in Diabetic Retinopathy
DOI: 10.12677/ACM.2022.125548, PDF,   
作者: 易静静:青海大学研究生院,青海 西宁;圈启芳*:青海大学附属医院,青海 西宁
关键词: 糖尿病糖尿病视网膜病变中性粒细胞/淋巴细胞比值Diabetes Mellitus Diabetic Retinopathy Neutrophil-Lymphocyte Ratio
摘要: 21世纪以来,随着糖尿病(Diabetes Mellitus, DM)患病人数的骤增,糖尿病视网膜病变(Diabetic Retinopathy, DR)发生率也大幅度增加。糖尿病视网膜病变作为糖尿病严重的微血管并发症之一,是一种涉及多个机制的复杂疾病。近年来,视网膜炎症在DR的发病机制中起着关键作用。其中中性粒细胞/淋巴细胞比值(Neutrophil-Lymphocyte Ratio, NLR)作为一种廉价且易于测量的实验室指标,用于指示全身炎症已被大量研究,故本文就NLR与糖尿病视网膜病变之间研究作一综述。
Abstract: Since twenty-first century, with the rapid increase of Diabetes Mellitus (DM) prevalence, the inci-dence of Diabetic Retinopathy (DR) has also increased significantly. Diabetic retinopathy is one of the serious microvascular complications of diabetes. It is a complex disease involving multiple mechanisms. In recent years, retinal inflammation plays a key role in the pathogenesis of DR. Among them, Neutrophil-Lymphocyte Ratio (NLR) is a cheap and easily measured laboratory indi-cator, indicating that systemic inflammation has been studied extensively. In this paper, the re-search on NLR and diabetic retinopathy is reviewed.
文章引用:易静静, 圈启芳. 中性粒与淋巴细胞比在糖尿病视网膜病变中的应用价值[J]. 临床医学进展, 2022, 12(5): 3800-3804. https://doi.org/10.12677/ACM.2022.125548

参考文献

[1] Kähm, K., Laxy, M., Schneider, U., Rogowski, W.H., Lhachimi, S.K. and Holle, R. (2018) Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany. Diabetes Care, 41, 971-978. [Google Scholar] [CrossRef] [PubMed]
[2] Zheng, Y., Ley, S.H. and Hu, F.B. (2018) Global Aetiology and Epidemi-ology of Type 2 Diabetes Mellitus and Its Complications. Nature Reviews Endocrinology, 14, 88-98. [Google Scholar] [CrossRef] [PubMed]
[3] Zimmet, P.Z., Magliano, D.J., Herman, W.H. and Shaw, J.E. (2014) Diabetes: A 21st Century Challenge. The Lancet Diabetes & Endocrinology, 2, 56-64. [Google Scholar] [CrossRef
[4] Cheung, N., Mitchell, P. and Wong, T.Y. (2010) Diabetic Retinopathy. The Lancet, 376, 124-136. [Google Scholar] [CrossRef
[5] Sabanayagam, C., Banu, R., Chee, M.L., et al. (2019) Inci-dence and Progression of Diabetic Retinopathy: A Systematic Review. The Lancet Diabetes & Endocrinology, 7, 140-149. [Google Scholar] [CrossRef
[6] Liu, Y., Song, Y., Tao, L., et al. (2017) Prevalence of Diabetic Retinopathy among 13473 Patients with Diabetes Mellitus in China: A Cross-Sectional Epidemiological Sur-vey in Six Provinces. BMJ Open, 7, e013199. [Google Scholar] [CrossRef] [PubMed]
[7] Wat, N., Wong, R.L. and Wong, I.Y. (2016) Associations between Diabetic Retinopathy and Systemic Risk Factors. Hong Kong Medical Journal, 22, 589-599. [Google Scholar] [CrossRef] [PubMed]
[8] Anwar, S.B., Asif, N., Naqvi, S. and Malik, S. (2019) Evaluation of Multiple Risk Factors Involved in the Development of Diabetic Retinopathy. Pakistan Journal of Medical Sciences, 35, 156-160. [Google Scholar] [CrossRef] [PubMed]
[9] Powell, E.D. and Field, R.A. (1964) Diabetic Retinopathy and Rheu-matoid Arthritis. The Lancet, 2, 17-18. [Google Scholar] [CrossRef
[10] Youngblood, H., Robinson, R., Sharma, A. and Sharma, S. (2019) Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy. International Journal of Molecular Sci-ences, 20, Article No. 4755. [Google Scholar] [CrossRef] [PubMed]
[11] Willermain, F., Scifo, L., Weber, C., Caspers, L., Perret, J. and Del-porte, C. (2018) Potential Interplay between Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy. International Journal of Molecular Sciences, 19, Article No. 1056. [Google Scholar] [CrossRef] [PubMed]
[12] Ighodaro, O.M. (2018) Molecular Pathways Associated with Oxidative Stress in Diabetes Mellitus. Biomedicine & Pharmacotherapy, 108, 656-662. [Google Scholar] [CrossRef] [PubMed]
[13] Zhang, W., Liu, H., Al-Shabrawey, M., Caldwell, R.W. and Caldwell, R.B. (2011) Inflammation and Diabetic Retinal Microvascular Complications. Journal of Cardiovascular Dis-ease Research, 2, 96-103. [Google Scholar] [CrossRef] [PubMed]
[14] Joussen, A.M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S.E. and Adamis, A.P. (2001) Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina. The Ameri-can Journal of Pathology, 158, 147-152. [Google Scholar] [CrossRef
[15] Kaplar, M., Kappelmayer, J., Veszpremi, A., Szabo, K. and Udvardy, M. (2001) The Possible Association of in Vivo Leukocyte-Platelet Heterophilic Aggregate Formation and the Development of Diabetic Angiopathy. Platelets, 12, 419-422. [Google Scholar] [CrossRef] [PubMed]
[16] Gouliopoulos, N.S., Kalogeropoulos, C., Lavaris, A., et al. (2018) Association of Serum Inflammatory Markers and Diabetic Retinopathy: A Review of Literature. European Review for Medical and Pharmacological Sciences, 22, 7113-7128.
[17] Feng, S., Yu, H., Yu, Y., et al. (2018) Levels of In-flammatory Cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy. Journal of Diabetes Research, 2018, Article ID: 8546423. [Google Scholar] [CrossRef] [PubMed]
[18] Chibber, R., Ben-Mahmud, B.M., Chibber, S. and Kohner, E.M. (2007) Leukocytes in Diabetic Retinopathy. Current Diabetes Reviews, 3, 3-14. [Google Scholar] [CrossRef] [PubMed]
[19] Rübsam, A., Parikh, S. and Fort, P.E. (2018) Role of Inflam-mation in Diabetic Retinopathy. International Journal of Molecular Sciences, 19, Article No. 942. [Google Scholar] [CrossRef] [PubMed]
[20] Cantor, H. and Simpson, E. (1975) Regulation of the Immune Re-sponse by subclasses of T lymphocytes. I. Interactions between Pre-Killer T Cells and Regulatory T Cells Obtained from Peripheral Lymphoid Tissues of Mice. European Journal of Immunology, 5, 330-336. [Google Scholar] [CrossRef] [PubMed]
[21] Hao, Y., Qi, Z., Ding, Y., Yu, X., Pang, L. and Zhao, T. (2019) Ef-fect of Interventional Therapy on IL-1β, IL-6, and Neutrophil-Lymphocyte Ratio (NLR) Levels and Outcomes in Patients with Ischemic Cerebrovascular Disease. Medical Science Monitor, 25, 610-617. [Google Scholar] [CrossRef
[22] 张羿, 朱正秋, 薛静. 外周血中性粒细胞与淋巴细胞比值预测晚期非小细胞肺癌免疫治疗疗效的价值[J]. 现代肿瘤医学, 2022, 30(1): 54-57.
[23] 王薇, 许春蕾, 布力布•吉利斯汉, 周宁, 李俊杰, 唐勇. 术前NLR、PLR在可切除壶腹周围癌预后中的价值[J]. 中国老年学杂志, 2022, 42(2): 306-311.
[24] Wei, Q.Q., Hou, Y.B., Zhang, L.Y., et al. (2022) Neutrophil-to-Lymphocyte Ratio in Sporadic Amyo-trophic Lateral Sclerosis. Neural Regeneration Research, 17, 875-880. [Google Scholar] [CrossRef] [PubMed]
[25] 朴美慈, 金仁顺. 术前NLR PLR与乳腺癌预后的相关性[J]. 中国肿瘤临床, 2015, 42(23): 1128-1131.
[26] Templeton, A.J., McNamara, M.G., Šeruga, B., et al. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Journal of the Na-tional Cancer Institute, 106, dju124. [Google Scholar] [CrossRef] [PubMed]
[27] 李文, 王璐, 张军成, 等. 术前外周血中性粒细胞及血小板与淋巴细胞比值对子宫内膜癌患者预后的影响[J]. 医学研究生学报, 2018, 31(1): 60-64.
[28] Azab, B., Zaher, M., Weiserbs, K.F., et al. (2010) Usefulness of Neutrophil to Lymphocyte Ratio in Predicting Short- and Long-Term Mortality after Non-ST-Elevation Myocardial Infarction. American Journal of Cardiology, 106, 470-476. [Google Scholar] [CrossRef] [PubMed]
[29] Hu, Z., Tan, S., Chen, S., et al. (2020) Diagnostic Value of Hematological Parameters Platelet to Lymphocyte Ratio and Hemoglobin to Platelet Ratio in Patients with Colon Cancer. Clinica Chimica Acta, 501, 48-52. [Google Scholar] [CrossRef] [PubMed]
[30] Wang, R.T., Zhang, J.R., Li, Y., Liu, T. and Yu, K.J. (2015) Neu-trophil-Lymphocyte Ratio Is Associated with Arterial Stiffness in Diabetic Retinopathy in Type 2 Diabetes. Journal of Diabetic Complications, 29, 245-249. [Google Scholar] [CrossRef] [PubMed]
[31] Woo, S.J., Ahn, S.J., Ahn, J., Park, K.H. and Lee, K. (2011) Elevated Systemic Neutrophil Count in Diabetic Retinopathy and Diabetes: A Hospital-Based Cross-Sectional Study of 30,793 Korean Subjects. Investigative Ophthalmology & Visual Science, 52, 7697-7703. [Google Scholar] [CrossRef] [PubMed]
[32] Yue, S., Zhang, J., Wu, J., Teng, W., Liu, L. and Chen, L. (2015) Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy. International Journal of Environmental Research and Public Health, 12, 10009-10019. [Google Scholar] [CrossRef] [PubMed]
[33] Ulu, S.M., Dogan, M., Ahsen, A., et al. (2013) Neutro-phil-to-Lymphocyte Ratio as a Quick and Reliable Predictive Marker to Diagnose the Severity of Diabetic Retinopathy. Diabetes Technology & Therapeutics, 15, 942-947. [Google Scholar] [CrossRef] [PubMed]
[34] Ciray, H., Aksoy, A.H., Ulu, N., Cizmecioglu, A., Gaipov, A. and Solak, Y. (2015) Nephropathy, but Not Angiographically Proven Retinopathy, Is Associated with Neutrophil to Lym-phocyte Ratio in Patients with Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes, 123, 267-271. [Google Scholar] [CrossRef] [PubMed]
[35] Wan, H., Wang, Y., Fang, S., et al. (2020) Associations between the Neutrophil-to-Lymphocyte Ratio and Diabetic Complications in Adults with Diabetes: A Cross-Sectional Study. Journal of Diabetes Research, 2020, Article ID: 6219545. [Google Scholar] [CrossRef] [PubMed]